ArticleWorld journal of surgical oncology2022

Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis.

Yan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.